David Windley
Stock Analyst at Jefferies
(3.75)
# 589
Out of 4,818 analysts
188
Total ratings
67.59%
Success rate
14.44%
Average return
Main Sectors:
Stocks Rated by David Windley
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CNC Centene | Upgrades: Hold | $53 → $64 | $60.23 | +6.26% | 27 | Apr 8, 2025 | |
| OSCR Oscar Health | Initiates: Underperform | $12 | $11.55 | +3.90% | 1 | Dec 10, 2024 | |
| HUM Humana | Downgrades: Hold | $419 → $253 | $258.71 | -2.21% | 18 | Oct 7, 2024 | |
| FTRE Fortrea Holdings | Downgrades: Hold | $25 → $21 | $5.50 | +281.82% | 2 | Sep 25, 2024 | |
| MEDP Medpace Holdings | Downgrades: Hold | $415 → $345 | $282.28 | +22.22% | 5 | Sep 25, 2024 | |
| CI The Cigna Group | Maintains: Buy | $402 → $422 | $337.07 | +25.20% | 17 | Sep 17, 2024 | |
| MOH Molina Healthcare | Maintains: Hold | $354 → $297 | $321.16 | -7.52% | 23 | Jul 24, 2024 | |
| IQV IQVIA Holdings | Downgrades: Hold | $266 → $242 | $143.61 | +68.51% | 4 | Jul 24, 2024 | |
| UNH UnitedHealth Group | Upgrades: Buy | $481 → $647 | $427.18 | +51.46% | 26 | Jul 17, 2024 | |
| NOTV Inotiv | Downgrades: Hold | $12 → $3.75 | $1.64 | +128.66% | 4 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $602 → $604 | $415.90 | +45.23% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $365 → $375 | $478.74 | -21.67% | 1 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 → $16 | $10.63 | +45.81% | 3 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $225 → $270 | $215.68 | +25.19% | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $14 → $16 | $14.44 | +7.34% | 3 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $323 → $536 | $214.95 | +149.36% | 10 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $39 → $29 | $21.70 | +33.64% | 2 | Nov 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $233 → $203 | $106.89 | +89.91% | 19 | Mar 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $276 → $302 | $136.79 | +120.78% | 14 | Sep 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $264 → $248 | $6.92 | +3,483.82% | 1 | Feb 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $1.35 | - | 5 | Oct 9, 2017 |
Centene
Apr 8, 2025
Upgrades: Hold
Price Target: $53 → $64
Current: $60.23
Upside: +6.26%
Oscar Health
Dec 10, 2024
Initiates: Underperform
Price Target: $12
Current: $11.55
Upside: +3.90%
Humana
Oct 7, 2024
Downgrades: Hold
Price Target: $419 → $253
Current: $258.71
Upside: -2.21%
Fortrea Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $25 → $21
Current: $5.50
Upside: +281.82%
Medpace Holdings
Sep 25, 2024
Downgrades: Hold
Price Target: $415 → $345
Current: $282.28
Upside: +22.22%
The Cigna Group
Sep 17, 2024
Maintains: Buy
Price Target: $402 → $422
Current: $337.07
Upside: +25.20%
Molina Healthcare
Jul 24, 2024
Maintains: Hold
Price Target: $354 → $297
Current: $321.16
Upside: -7.52%
IQVIA Holdings
Jul 24, 2024
Downgrades: Hold
Price Target: $266 → $242
Current: $143.61
Upside: +68.51%
UnitedHealth Group
Jul 17, 2024
Upgrades: Buy
Price Target: $481 → $647
Current: $427.18
Upside: +51.46%
Inotiv
May 14, 2024
Downgrades: Hold
Price Target: $12 → $3.75
Current: $1.64
Upside: +128.66%
Apr 19, 2024
Maintains: Buy
Price Target: $602 → $604
Current: $415.90
Upside: +45.23%
Apr 19, 2024
Maintains: Hold
Price Target: $365 → $375
Current: $478.74
Upside: -21.67%
Mar 25, 2024
Upgrades: Buy
Price Target: $15 → $16
Current: $10.63
Upside: +45.81%
Mar 4, 2024
Maintains: Buy
Price Target: $225 → $270
Current: $215.68
Upside: +25.19%
Mar 1, 2024
Maintains: Hold
Price Target: $14 → $16
Current: $14.44
Upside: +7.34%
Feb 7, 2024
Upgrades: Buy
Price Target: $323 → $536
Current: $214.95
Upside: +149.36%
Nov 1, 2023
Downgrades: Hold
Price Target: $39 → $29
Current: $21.70
Upside: +33.64%
Mar 28, 2023
Maintains: Hold
Price Target: $233 → $203
Current: $106.89
Upside: +89.91%
Sep 14, 2021
Maintains: Buy
Price Target: $276 → $302
Current: $136.79
Upside: +120.78%
Feb 25, 2021
Maintains: Hold
Price Target: $264 → $248
Current: $6.92
Upside: +3,483.82%
Oct 9, 2017
Upgrades: Buy
Price Target: n/a
Current: $1.35
Upside: -